DexCom (DXCM) Issues Q4 Sales Guidance in 8-K
More News related to DXCM
- DexCom Appoints Nicholas Augustinos as Board Member
- DexCom To Present at Lazard Capital Markets 6th Annual Healthcare Conference
- DexCom (DXCM) Posts Q3 Loss of 29c, Beats by 3c
- DexCom Inc. Reports Third Quarter 2009 Financial Results
- Trading Radar for 11/04: Cisco (CSCO), Comcast (CMCSA), Tyco (TEL), Molson Coors (TAP) Report
More News related to Guidance
- HJ Heinz (HNZ) Tops Q2 EPS by 6c; Raises FY10 EPS Guidance
- Cracker Barrel (CBRL) Tops Q1 EPS by 16c, Guide FY EPS Above the Street
- Hillenbrand (HI) Posts In-Line Q4 EPS; Guides
- DSW (DSW) Posts Q3 EPS of $0.60, Tops by 14c; Raises FY09 EPS Guidance
- Kinder Morgan Energy (KMP) Updates 2010 Guidance
In a Form 8-K, DexCom (Nasdaq: DXCM) sees Q4 sales of about $2.4 million, with unit sales of approximately 1,200 starter kits and a sequential increase in sensor revenues of approximately 25% compared to Q308.
DexCom, Inc., a medical device company, engages in the design, development, and commercialization of continuous glucose monitoring systems for people with diabetes in the United States.
Related Categories
GuidanceStocks Mentioned
+0.00Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
